1. P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Broijl, A.; van de Donk, N.; Bosch, F.; Mateos, M. V.; Rodriguez-Otero, P.; Tucci, A.; Ghia, P.; Adang, A.; Parren, P.; Tuinhof, I.; Umarale, S.; Winograd, B.; van der Vliet, H.; Kater, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P607: A NOVEL LYMPH NODE-MIMICKING 3D CULTURE SYSTEM DISPLAYS LONG-TERM T CELL-DEPENDENT CLL PROLIFERATION AND SURVIVAL. (23rd June 2022) Authors: Haselager, M.; Perelaer, E.; Kater, A.; Eldering, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110. (23rd June 2022) Authors: Hengeveld, P.; Ertem, Y. E.; Dubois, J.; Mellink, C.; van der Kevie-Kersemaekers, A.-M.; Evers, L.; Heezen, K.; Kolijn, P. M.; Mook, O.; Motazacker, M. M.; Nasserinejad, K.; Kersting, S.; Westerweel, P.; Niemann, C.; Kater, A.; Langerak, A.; Levin, M.-D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P644: THE LIFE EXPECTANCY OF PATIENTS WITH HAIRY CELL LEUKEMIA VERGES UPON THE LIFE EXPECTANCY OF THE GENERAL POPULATION: A POPULATION-BASED STUDY IN THE NETHERLANDS. (23rd June 2022) Authors: Dinmohamed, A.; Maas, C.; Visser, O.; Doorduijn, J.; Mous, R.; Raymakers, R.; Kater, A.; Posthuma, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗